Prudential Financial’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Buy |
117,516
+89,107
| +314% | +$3.85M | 0.01% | 896 |
|
|
2025
Q1 | $982K | Buy |
28,409
+17,980
| +172% | +$622K | ﹤0.01% | 1578 |
|
|
2024
Q4 | $286K | Sell |
10,429
-3,360
| -24% | -$92.2K | ﹤0.01% | 1999 |
|
|
2024
Q3 | $351K | Sell |
13,789
-718
| -5% | -$18.3K | ﹤0.01% | 2358 |
|
|
2024
Q2 | $367K | Buy |
14,507
+1,447
| +11% | +$36.7K | ﹤0.01% | 2296 |
|
|
2024
Q1 | $404K | Buy |
13,060
+3,045
| +30% | +$94.2K | ﹤0.01% | 2241 |
|
|
2023
Q4 | $404K | Buy |
10,015
+1,624
| +19% | +$65.6K | ﹤0.01% | 2215 |
|
|
2023
Q3 | $221K | Buy |
+8,391
| New | +$221K | ﹤0.01% | 2365 |
|
|
2022
Q1 | – | Sell |
-9,213
| Closed | -$474K | – | 2612 |
|
|
2021
Q4 | $474K | Sell |
9,213
-3,260
| -26% | -$168K | ﹤0.01% | 2219 |
|
|
2021
Q3 | $650K | Buy |
12,473
+412
| +3% | +$21.5K | ﹤0.01% | 2031 |
|
|
2021
Q2 | $736K | Sell |
12,061
-44
| -0.4% | -$2.69K | ﹤0.01% | 1977 |
|
|
2021
Q1 | $746K | Sell |
12,105
-22,989
| -66% | -$1.42M | ﹤0.01% | 1972 |
|
|
2020
Q4 | $2.5M | Buy |
35,094
+29,284
| +504% | +$2.08M | ﹤0.01% | 1322 |
|
|
2020
Q3 | $218K | Buy |
+5,810
| New | +$218K | ﹤0.01% | 2271 |
|